Why do men have worse COVID-19-related outcomes? A systematic review and meta-analysis with sex adjusted for age
Braz. j. med. biol. res
;
55: e11711, 2022. graf
Article
in English
|
LILACS-Express
| LILACS
| ID: biblio-1360236
ABSTRACT
We aimed to study the mechanism behind worse coronavirus disease-19 (COVID-19) outcomes in men and whether the differences between sexes regarding mortality as well as disease severity are influenced by sex hormones. To do so, we used age as a covariate in the meta-regression and subgroup analyses. This was a systematic search and meta-analysis of observational cohorts reporting COVID-19 outcomes. The PubMed (Medline) and Cochrane Library databases were searched. The primary outcome was COVID-19-associated mortality and the secondary outcome was COVID-19 severity. The study was registered at PROSPERO 42020182924. For mortality, men had a relative risk of 1.36 (95%CI 1.17 to 1.59; I2 63%, P for heterogeneity <0.01) compared to women. Age was not a significant covariate in meta-analysis heterogeneity (P=0.393) or subgroup analysis. For disease severity, being male was associated with a relative risk of 1.29 (95%CI 1.19 to 1.40; I2 48%, P for heterogeneity <0.01) compared to the relative risk of women. Again, age did not influence the outcomes of the meta-regression (P=0.914) or subgroup analysis. Men had a higher risk of COVID-19 mortality and severity regardless of age, decreasing the odds of hormonal influences in the described outcomes.
Full text:
Available
Index:
LILACS (Americas)
Type of study:
Etiology study
/
Systematic reviews
Language:
English
Journal:
Braz. j. med. biol. res
Journal subject:
Biology
/
Medicine
Year:
2022
Type:
Article
Affiliation country:
Brazil
/
Canada
Institution/Affiliation country:
Hospital Nossa Senhora da Conceição/BR
/
Mount Sinai Hospital, University of Toronto/CA
/
Universidade Federal do Rio Grande do Sul/BR
Similar
MEDLINE
...
LILACS
LIS